Laurus Labs Ltd.
NSE: LAURUSLABS | BSE: 540222
₹1,327.30
₹3.70
(0.28%)
As on 18-May-2026IST
Market cap
₹71,647 Cr
Revenue (TTM)
₹6,813 Cr
P/E Ratio
80.6
P/B Ratio
13.5
Div. Yield
0.2 %
Quality Score
2/10
Growth Score
6/10
Valuation Score
2/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹889 Cr
-
ROE
8.3 %
-
ROCE
10.2 %
-
Industry P/E
59.42
-
EV/EBITDA
40.3
-
Debt to Equity
0.1
-
Book Value
₹98.2
-
EPS
₹16.5
-
Face value
2
-
Shares outstanding
539,856,582
10 Years Aggregate
CFO
₹5,406.87 Cr
EBITDA
₹8,501.77 Cr
Net Profit
₹3,977.62 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Laurus Labs
| 19.8 | 16.9 | 31.0 | 120.1 | 62.1 | 22.9 | -- |
|
BSE Healthcare
| 8.9 | 8.8 | 9.5 | 11.4 | 27.0 | 14.4 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Laurus Labs
| 80.0 | 39.2 | 14.6 | -30.4 | 52.5 | 379.5 | -6.1 |
|
BSE Mid Cap
| 1.1 | 25.8 | 45.5 | 1.4 | 39.2 | 19.9 | -3.0 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Laurus Labs
|
1,327.3 | 71,647.1 | 6,812.9 | 889.9 | 19.0 | 17.6 | 80.6 | 13.5 |
| 2,799.1 | 22,902.2 | 1,339.4 | 356.4 | 33.2 | 23.2 | 64.3 | 13.9 | |
| 519.8 | 8,186.1 | 4,359.0 | 256.4 | 8.4 | 8.3 | 32.1 | 2.5 | |
| 724.4 | 14,230.2 | 7,344.9 | 670.6 | 10.9 | 13.7 | 21.1 | 2.5 | |
| 428.1 | 16,431.3 | 2,268.6 | 150.1 | 10.6 | 5.4 | 91.7 | 4.2 | |
| 731.5 | 18,126.3 | 5,365.6 | 595.0 | 16.6 | 13.3 | 30.5 | 3.6 | |
| 1,811.3 | 20,737.1 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.6 | |
| 175.1 | 23,261.8 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 466.3 | 18,819.1 | 3,738.7 | 316.7 | 12.5 | 7.5 | 59.4 | 3.9 | |
| 1,571.5 | 25,547.8 | 3,373.0 | 199.0 | 12.6 | 5.9 | 119.9 | 5.2 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Laurus Labs: What hinders its growth?
3 min read•By Hemkesh Khattar
Companies falling short of cash
2 min read•By Rajan Gulati
About Laurus Labs
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV),... antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India. Read more
-
Incorporated
2005
-
Chairman
Ravindranath Kancherla
-
Managing Director
--
-
Headquarters
Vishakhapatnam, Andhra Pradesh
-
Website
Looking for more details about Laurus Labs Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Laurus Labs
What is the current share price of Laurus Labs Ltd Today?
The share price of Laurus Labs Ltd is ₹1,327.30 (NSE) and ₹1,327.15 (BSE) as of 18-May-2026 IST. Laurus Labs Ltd has given a return of 62.06% in the last 3 years.
What is the current PB & PE ratio of Laurus Labs Ltd?
The P/E ratio of Laurus Labs Ltd is 80.61 times as on 18-May-2026, a 36 premium to its peers’ median range of 59.42 times.
The P/B ratio of Laurus Labs Ltd is 13.52 times as on 18-May-2026, a 280 premium to its peers’ median range of 3.56 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
92.37
|
7.44
|
|
2024
|
133.90
|
5.16
|
|
2023
|
20.12
|
3.92
|
|
2022
|
38.31
|
9.49
|
|
2021
|
19.75
|
7.49
|
What is the 52 Week High and Low of Laurus Labs Ltd?
The 52-week high and low of Laurus Labs Ltd are Rs 1,333.50 and Rs 584.50 as of 19-May-2026.
What is the market cap of Laurus Labs Ltd?
Laurus Labs Ltd has a market capitalisation of ₹ 71,647 Cr as on 18-May-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in Laurus Labs Ltd?
Before investing in Laurus Labs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.